Autopsy report · NCT06660030

Factors Influencing Tamoxifen Adherence in Women With Breast Cancer Receiving Tamoxifen in Botswana.

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“Lack of funds”

The sponsor’s own words in the registry.

Life of this trial

Registered 8 months after it had already started.
Ran for about 1 year 9 months before it stopped.
10 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Sponsor: University of Pennsylvania
Sponsor type: University, hospital or other
Conditions: Breast Cancer Female
Interventions: No intervention
Participants: 10
Sites: 1
Countries: Botswana

Trials that died the same way

Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma
“lack of funding” (89% match in meaning)

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.